
Novo Nordisk’s Leadership Transition: Charting a Course for the Future
Novo Nordisk Announces CEO Transition and Board Changes In a significant move that has sent ripples through the pharmaceutical industry, Novo Nordisk, a leading name in healthcare, has announced changes to its executive leadership and Board of Directors. This strategic shift, effective as of May 16, 2025, marks a pivotal moment for the company as…